Interagency Patent Coordination and Improvement Act of 2023

Cost and committee reports

Official records Congress.gov attaches to H.R. 1717.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. NEGUSE, as printed in the Congressional Record (Vol. 169, No. 52, March 22, 2023, Page H1329):
  Article I, Section 8 The single subject of this legislation is: Establish an interagency task force between the U.S. Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information with respect to patents.
  Source: Congress.gov, Congressional Record March 22, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  242 characters

  Congress.gov bill record

  H.R. 1717, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/1717

  Record last updated by Congress.gov

  December 5, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  89ef3c9ae69cc5b52e19c5cc85423e34a9f48bcc41571c2cfba46bd9a1b392fd

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of December 5, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 1717, last updated December 5, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.